Vector Priming Reduces the Immunogenicity of Salmonella-Based Vaccines in Nramp1+/+ Mice
AUTOR(ES)
Vindurampulle, Christofer J.
FONTE
American Society for Microbiology
RESUMO
The present studies in Nramp1−/− BALB/c and Nramp1+/+ CBA mice question the significance of this genotype as a determinant of the level of gut colonization following oral administration of naturally attenuated or highly virulent Salmonella strains. In line with previous results in BALB/c hosts, vector priming of CBA mice with Salmonella enterica serovar Stanley was found to significantly compromise the immunogenicity of a recombinant construct expressing a foreign pilus protein.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=152061Documentos Relacionados
- Impact of Vector Priming on the Immunogenicity of Recombinant Salmonella Vaccines
- Improved Efficiency of a Salmonella-Based Vaccine against Human Papillomavirus Type 16 Virus-Like Particles Achieved by Using a Codon-Optimized Version of L1
- Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines
- Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines.
- Immunogenicity of Plague Vaccines in Mice and Guinea Pigs